Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01675063 · ClinicalTrials.gov registry record · NA
Minimally Invasive Cardiac Output Monitoring Device
A NA study of Cardiac Event, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT01675063 is a NA study of Cardiac Event that has completed, run by University of Michigan. The registered enrollment target is 77 participants, below the 1,063-participant average among 3 other Cardiac Event trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01675063, a NA study of Cardiac Event, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this collaborative study is to advance the novel "pulse contour analysis" to the point at which it can be incorporated into a real-time device. The specific objective is to establish an auto-calibration algorithm that conveniently yields cardiac output (CO) in units of liters-per-minute. To achieve this objective, the waveforms for analysis and reference pulmonary artery catheter CO measurements will be recorded from critically ill patients and then analyzed off-line at Retia Medical. Successful completion of this study may ultimately help lead to improved outcomes of critically ill patients.
Conditions Studied
Interventions
- DEVICE Retia Non-Invasive Sensors
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01675063
The ClinicalTrials.gov registry entry for NCT01675063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,063-participant average among 3 other Cardiac Event trials with a reported enrollment target (93% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Event appearing as the primary indexed condition, and to 1 intervention - of which Retia Non-Invasive Sensors is the first listed.
NCT01675063 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01675063 about?
NCT01675063 is a clinical study titled "Minimally Invasive Cardiac Output Monitoring Device". The overall goal of this collaborative study is to advance the novel "pulse contour analysis" to the point at which it can be incorporated into a real-time device. The specific objective is to establish an auto-calibration algorithm that conveniently yields cardiac output (CO) in units of liters-per...
What is the current status of trial NCT01675063?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2012-08. Estimated completion is 2015-10.
What conditions does trial NCT01675063 study?
This clinical trial studies the following conditions: Cardiac Event.
What interventions are being tested in trial NCT01675063?
The interventions under investigation include: Retia Non-Invasive Sensors (DEVICE).
Who is sponsoring clinical trial NCT01675063?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01675063 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Event
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.